Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

NCT06642272 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT06642272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06642272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Lead sponsor
Herlev and Gentofte Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
October 10, 2024
Completion date
December 31, 2028
Enrollment
17,200 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetes mellitus, type 2, heart failure